Related Experiment Video
Updated: Sep 11, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Pediatric metabolic dysfunction-associated steatotic liver disease and the gut microbiome: from research landscape to
Lu Jiang1,2,3, Lan-Duoduo Du1, Jing Zeng4
1Division of Pediatric Gastroenterology and Nutrition, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children is linked to gut bacteria changes. Understanding the gut-liver axis offers new ways to diagnose and treat this common liver condition.
Area of Science:
- Hepatology
- Microbiology
- Pediatrics
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease in children.
- Pediatric MASLD encompasses a range from simple steatosis to cirrhosis and hepatocellular carcinoma.
- Pathogenesis involves genetic, epigenetic, environmental factors, and gut microbiota alterations.
Purpose of the Study:
- To review clinical studies on gut microbiota and microbial product alterations in pediatric MASLD.
- To explore the potential of targeting the gut-liver axis for diagnosis and therapy.
- To discuss therapeutic strategies including diet, medication, and probiotics.
Main Methods:
- Review of clinical studies focusing on gut microbiota and microbial products in pediatric MASLD.
- Analysis of short-chain fatty acids, bile acids, and ethanol in relation to disease pathogenesis.
- Summarization of current research on dietary, pharmacological, and probiotic interventions.
Main Results:
- Alterations in gut microbiota and microbial products are implicated in pediatric MASLD pathogenesis.
- Existing research is limited by small sample sizes and methodological inconsistencies.
- Dietary modification, pharmacological treatments, and probiotics show therapeutic potential.
Conclusions:
- The gut-liver axis plays a crucial role in pediatric MASLD.
- Further research is needed to overcome current limitations and develop effective diagnostic and therapeutic tools.
- Targeting the gut microbiome may offer novel strategies for managing pediatric MASLD.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, has become the most common form of chronic liver disease in children. The spectrum of pediatric MASLD ranges from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and in rare cases, hepatocellular carcinoma. Its pathogenesis involves a complex interplay among genetic, epigenetic, and environmental factors, along with alterations in the gut microbiota and its associated metabolites. Given the staggering prevalence and the distinct etiopathogenesis of pediatric MASLD, characterization of the gut microbiota and microbial products could facilitate the development of diagnostic tools and inform targeted therapeutic strategies. Current research on the gut microbiome in the context of pediatric MASLD is limited by small sample size, inadequate use of liver biopsy, methodological inconsistencies in sequencing, and confounding effects from metabolic comorbidities. In this review, we summarize clinical studies on alterations in the gut microbiota and microbial products (short-chain fatty acids, bile acids, and ethanol) that impact the pathogenesis of pediatric MASLD. We discuss the therapeutic potential of dietary modification, pharmacological treatments, and probiotics in improving disease progression by summarizing current clinical studies. Enhancing our understanding of the gut-liver axis may aid in the development of effective therapeutic strategies for pediatric MASLD.
Related Concept Videos
Inborn Errors of Metabolism
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Lysosomal Hydrolases
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

